Perispinal etanercept for treatment of Alzheimer's disease

Current Alzheimer Research

Volumn 4, Issue 5, 2007, Pages 550-552

  Tobinick, Edward ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Private Medical Group Inc   (United States)

Author keywords

Alzheimer's; Cytokines; Dementia; Etanercept; Synaptic scaling; TNF

Indexed keywords

AMYLOID; ETANERCEPT; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; COGNITION; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG MECHANISM; HUMAN; NERVE CELL NETWORK; NEUROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; TREATMENT OUTCOME;

EID: 37049002092     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720507783018217     Document Type: Conference Paper

References (35)

1. McGeer PL, Rogers J, McGeer EG. Inflammation, antiinflammatory agents and Alzheimer disease: the last 12 years. J Alzheimers Dis 2006;9(3 Suppl):271-6.
2. Rosenberg PB. Clinical aspects of inflammation in Alzheimer's disease. Int Rev Psychiatry 17(6):503-14 (2005).
3. Aisen PS, Davis KL, Berg JD, Schafer K, Campbell K, Thomas RG, et al. A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology 54(3):588-93 (2000).
4. Aisen PS. Anti-inflammatory agents in Alzheimer's disease. Curr Neurol Neurosci Rep 2(5):405-9 (2002).
5. Feldmann M, Maini RN. Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med 9(10):1245-50 (2003).
6. Tarkowski E, Andreasen N, Tarkowski A, Blennow K. Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry 74(9):1200-5 (2003).
7. Fillit H, Ding WH, Buee L, Kalman J, Altstiel L, Lawlor B, et al. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci Lett 129(2):318-20 (1991).
8. Zuliani G, Ranzini M, Guerra G, Rossi L, Munari MR, Zurlo A, et al. Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. J Psychiatr Res 41(8):686-93 (2007).
9. Klegeris A, Walker DG, McGeer PL. Interaction of Alzheimer betaamyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factoralpha. Brain Res 747(1):114-21 (1997).
10. Blasko I, Marx F, Steiner E, Hartmann T, Grubeck-Loebenstein B. TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. Faseb J 13(1):63-8 (1999).
11. Combs CK, Karlo JC, Kao SC, Landreth GE. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21(4):1179-88 (2001).
12. Floden AM, Li S, Combs CK. Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. J Neurosci 25(10):2566-75 (2005).
13. Mbebi C, de Aguilar JL, See V, Dupuis L, Frossard N, Mercken L, et al. Antibody-bound beta-amyloid precursor protein stimulates the production of tumor necrosis factor-alpha and monocyte chemoattractant protein-1 by cortical neurons. Neurobiol Dis 19(1-2):129-41 (2005).
14. Wang Q, Wu J, Rowan MJ, Anwyl R. Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor. Eur J Neurosci 22(11):2827-32 (2005).
15. Jekabsone A, Mander PK, Tickler A, Sharpe M, Brown GC. Fibrillar beta-amyloid peptide Abeta1-40 activates microglial proliferation via stimulating TNF-alpha release and H2O2 derived from NADPH oxidase: a cell culture study. J Neuroinflammation 3:24 (2006).
16. Meme W, Calvo CF, Froger N, Ezan P, Amigou E, Koulakoff A, et al. Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by beta-amyloid. Faseb J 20(3):494-6 (2006).
17. Zou JY, Crews FT. TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res 1034(1-2):11-24 (2005).
18. Taylor DL, Jones F, Kubota ES, Pocock JM. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J Neurosci 25(11):2952-64 (2005).
19. De A, Krueger JM, Simasko SM. Glutamate induces the expression and release of tumor necrosis factor-alpha in cultured hypothalamic cells. Brain Res 1053(1-2):54-61 (2005).
20. Small DH. Mechanisms of synaptic homeostasis in Alzheimer's disease. Curr Alzheimer Res 1(1):27-32 (2004).
21. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, et al. Control of synaptic strength by glial TNFalpha. Science 295(5563):2282-5 (2002).
22. Pickering M, Cumiskey D, O'Connor JJ. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 90(5):663-70 (2005).
23. Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature 440(7087):1054-9 (2006).
24. Mayhan WG, Heistad DD. Permeability of blood-brain barrier to various sized molecules. Am J Physiol 248(5 Pt 2):H712-8 (1985).
25. Tobinick EL, Britschgi-Davoodifar S. Perispinal TNF-alpha inhibition for discogenic pain. Swiss Med Wkly 133(11-12):170-7 (2003).
26. Tobinick E, Davoodifar S. Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients. Curr Med Res Opin 20(7):1075-85 (2004).
27. Tobinick E, Vega CP. The cerebrospinal venous system: anatomy, physiology, and clinical implications. Med Gen Med 8(1):53 (2006).
28. Epstein HM, Linde HW, Crampton AR, Ciric IS, Eckenhoff JE. The vertebral venous plexus as a major cerebral venous outflow tract. Anesthesiology 32(4):332-7 (1970).
29. Batson OV. The Function of the Vertebral Veins and their role in the spread of metastases. Annals of Surgery 112:138-149 (1940).
30. Batson OV. The Vertebral Vein System as a Mechanism for the Spread of Metastases. American Jouranl of Roentgenology and Radium Therapy 48(6):715-718 (1942).
31. Batson OV. The Vertebral Vein System, Caldwell Lecture, 1956. American Journal of Roentgenology 78(2) (1957).
32. Gisolf J, van Lieshout JJ, van Heusden K, Pott F, Stok WJ, Karemaker JM. Human cerebral venous outflow pathway depends on posture and central venous pressure. J Physiol 560(Pt 1):317-27 (2004).
33. Anderson R. Diodrast studies of the vertebral and cranial venous systems to show their probable role in cerebral metastases. J Neurosurg 8(4):411-22 (1951).
34. Tobinick E, Gross H, Weinberger A, Cohen H. TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study. Med Gen Med 8(2):25 (2006).
35. Amgen. Enbrel(R) package insert. Thousand Oaks, CA; (2005).